|
Genotype
|
Total (n)
|
CR (n, %)
|
Non-CR (n, %)
|
OR (95% CI)
|
p
|
OR (95% CI)a
|
pa
|
|---|
|
rs4082155
|
|
AA
|
157
|
96 (61.1%)
|
61 (38.9%)
|
1.00 (reference)
| |
1.00 (reference)
| |
|
AG
|
266
|
184 (69.2%)
|
82 (30.8%)
|
0.701 (0.464–1.060)
|
0.092
|
0.562 (0.340–0.931)
|
0.025*
|
|
GG
|
123
|
88 (71.5%)
|
35 (28.5%)
|
0.626 (0.377–1.039)
|
0.07
|
0.501 (0.265–0.946)
|
0.033*
|
|
AA
|
157
|
96 (61.1%)
|
61 (38.9%)
|
1.00 (reference)
| |
1.00 (reference)
| |
|
AG + GG
|
389
|
272 (69.9%)
|
117 (30.1%)
|
0.677 (0.460–0.997)
|
0.048*
|
0.544 (0.338–0.876)
|
0.012*
|
|
rs6767907
|
|
GG
|
237
|
155 (65.4%)
|
82 (34.6%)
|
1.00 (reference)
| |
1.00 (reference)
| |
|
GA
|
242
|
171 (70.7%)
|
71 (29.3%)
|
0.698 (0.396–1.230)
|
0.213
|
0.668 (0.323–1.379)
|
0.275
|
|
AA
|
67
|
42 (62.7%)
|
25 (37.3%)
|
0.889 (0.506–1.560)
|
0.681
|
1.126 (0.548–2.317)
|
0.746
|
|
rs76208147
|
|
CC
|
422
|
273 (64.7%)
|
149 (35.3%)
|
1.00 (reference)
| |
1.00 (reference)
| |
|
CT
|
110
|
84 (76.4%)
|
26 (23.6%)
|
0.567 (0.350–0.919)
|
0.021*
|
0.600 (0.342–1.053)
|
0.075
|
|
TT
|
14
|
11 (78.6%)
|
3 (21.2%)
|
0.500 (0.137–1.819)
|
0.293
|
0.545 (0.114–2.604)
|
0.447
|
- *p < 0.05
- a Adjusted for age, risk stratification, LDH and WBC
